메틸페니데이트에 의한 도파민운반체영상의 흡수 감소

키워드

참고문헌 (7)

1. Diaz-Corrales FJ, "Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson’s disease", Eur J Nucl Med Mol Imaging, 37, pp.556~564 (2010)
2. Oh M, "Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy", J Nucl Med, 53, pp.399~406 (2012)
3. Kraemmer J, "Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts", Mov Disord, 29, pp.1767~1773 (2014)
4. FP-CIT SPECT : potential effects of drugs, "Eur J Nucl Med Mol Imaging", 2008, 424~438
5. Vles JS, "Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder(ADHD)", Neuropediatrics, 34, pp.77~80 (2003)
6. Spencer TJ, "PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short-and long-acting oral methylphenidate", Am J Psychiatry, 163, pp.387~395 (2006)
7. Djang DS, "SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0", J Nucl Med, 53, pp.154~163 (2012)

관련 논문AI추천